Genia Turanova, Chief Investment Strategist for Game-Changing Stocks and Fast-Track Millionaire, is a financial writer and money manager whose experience includes serving for more than a decade as a portfolio manager and Investment Committee member for a New York-based money management firm. Genia also researched, wrote and managed recommendations for several investment advisories. From 2011 to 2016, she served as Editor of the award-winning Leeb Income Performance newsletter. Genia also wrote for The Complete Investor, another award winner, from 2003 to 2016. During that time, Genia was responsible for several portfolios, including the "Income/Value" portfolio and the "FastTrack" portfolio. Genia's academic credentials include an MBA in Finance and Investments from the Zicklin School of Business, Baruch College in New York City. Genia is a CFA Charterholder.
Analyst Articles
Investors always face a balancing act when it comes to biotechs: while any company’s ultimate success can be measured in its ability to make money, for biotech companies, especially early in the cycle, it’s their new drugs that matter most. Case in point: CRISPR… Read More
A 15% rally this morning in “barcode of everything” company Digimarc (Nasdaq: DMRC) has brought the year-to-date return on the shares to more than 100%. Today’s high of about $30 a share is more than double the recent low of $14.36 on Dec. 24. The… Read More
Should I stay or should I go? If you’ve been singing this 1981 tune by the English punk rock...
Read More
Should I stay or should I go? If you’ve been singing this 1981 tune by the English punk rock band The Clash to yourself since late September, you are not alone. In the fourth-quarter...
Read More
We love round numbers and anniversaries. And in just a few days, in early March 2019, investors will be celebrating a big one — the 10-year birthday of this bull market. Having officially started in a trough on March 9, 2009, the bull market… Read More
In this week’s issue, I talked at length about our snap-back stocks, the ones that declined disproportionately during the fourth-quarter selloff and are now coming back to life. Count Talend (Nasdaq: TLND) among those snap-back winners. Having jumped by more than 20% in this morning’s… Read More
After a dismal fourth quarter, disheartened investors needed a snap-back rally… and they got...
Read More
After a dismal fourth quarter, disheartened investors needed a snap-back rally… and they got it in spades: The S&P 500 rallied 15% from the market’s lows on December 24 through the...
Read More
An exceptionally strong fourth quarter just reported by our cybersecurity firm CyberArk (Nasdaq: CYBR) has propelled its shares by about 18% this morning. This action is good enough for a 15% gain on this stock just two weeks (we added CYBR to the portfolio… Read More
Should I stay or should I go? If you’ve been singing this 1981 tune by the English punk rock band the Clash to yourself since late September, you are not alone. In the fourth-quarter selloff, U.S. equities lost $4 trillion in… Read More
Since 1951, the American Cancer Society has been releasing a detailed report on the status of this...
Read More
Since 1951, the American Cancer Society has been releasing a detailed report on the status of this dreaded disease, and our progress in fighting it. A valuable feature of these publications is...
Read More
If there is a single trait that all game-changing stocks, regardless of their size or industry,...
Read More
If there is a single trait that all game-changing stocks, regardless of their size or industry, share, it would be their outsized growth potential. This comes with the territory. An innovative...
Read More
